Eric Schlorff
CEO, Treasurer, President & Executive DirectorMr. Eric Schlorff serves as Chief Executive Officer and Executive Director of SeaStar Medical Holding Corporation since July 2019 and serves as its President and also served as its Interim Chief Financial Officer and Treasurer since August 19, 2025. He served as Chief Operating Officer at LMF Acquisition Opportunities, Inc. (formerly known as SeaStar Medical Holding Corporation (formerly known as SeaStar Medical, Inc.)) from March 2019 to July 2019. Mr. Schlorff also previously served as a Director of SeaStar Medical from June 2016 to May 2019. From 1999 to 2019, Mr. Schlorff served in multiple roles at the Dow Chemical Company in Midland, Michigan and Indianapolis, Indiana. From June 2016 to February 2019, Mr. Schlorff served as Global Director of Alternative Investments for the Dow Chemical Pension Plan and Global Finance Leader for Crop Protection & Seeds at Dow AgroSciences from June 2013 to June 2016. Additional leadership positions held by Mr. Schlorff include the Global Market Intelligence Leader at Dow AgroSciences, Global Financial Manager of Royalties at Dow Agrosciences, Senior Investment Manager of Alternative Investments at Dow Chemical Company, New Business Development of Pharmaceuticals at Dow Chemical Company, Global Financial Analyst within the New Businesses division at Dow Chemical Company and Global Financial Analyst within Dow AgroSciences at Dow Chemical Company. Mr. Schlorff has a bachelor’s degree in chemistry and biology from Mac Murray College, an M.S. in pharmacology from Southern Illinois University School of Medicine and a master’s in business administration from University of Illinois Urbana-Champlain.
Positions
- Company NameSeaStar Medical Holding CorporationStock CodeICUPositionCEO, Treasurer, President & Executive DirectorRelated SecuritiesColleagues
- JAJennifer A. BairdIndependent Chairman of the Board
- MMMichael MessingerChief Financial Officer
- KCKevin ChungChief Medical Officer
- HDH. David HumesCo-Founder & Scientific Advisor
- TMTom MullenVice President of Operations & Product Development
- JNJohn NeumanIndependent Director
- GMGlenn Matthew ChertowMember of Medical Advisory Board
- RLRavindra L. MehtaMember of Medical Advisory Board
